Global World Health

globalworldcitizen.com

Novo Nordisk’s Amycretin Outperforms Wegovy in Initial Trial: Insights into the New Weight Loss Pill from the Maker of Ozempic

Mar 7, 2024,12:28pm EST Novo Nordisk, the manufacturer behind Ozempic, has hinted at a potential successor to its widely successful weight loss drug Wegovy. This revelation comes amidst a flurry […]

Novo Nordisk’s Amycretin Outperforms Wegovy in Initial Trial: Insights into the New Weight Loss Pill from the Maker of Ozempic Read More »